Tue, Nov 25, 2014, 5:10 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Puma Biotechnology, Inc. Message Board

Title   Replies Latest Post

The News Doesn't Make Sense

Nov 13, 2014 7:51 PM by m.habie
0/0 27 Nov 16, 2014 4:57 PM by allanacetone

Why only down to $226 in after hours?

Nov 13, 2014 4:40 PM by barrel.denis
1/1 7 Nov 13, 2014 9:04 PM by allanacetone

This stock is Way overpriced...

Nov 14, 2014 11:48 AM by budcozy121
3/2 2 Nov 15, 2014 9:20 AM by dobald1975

read NYTIMES, 6/9/14 "OUTSMARTING BREAST CANCER" by Jane Brody "by using...

Oct 30, 2014 10:58 AM by sayz.simmon
3/1 2 Nov 18, 2014 8:09 PM by sayz.simmon

This thing better holds $215 !!!!! Poeple got sucked in again !!!!!!

Nov 17, 2014 11:37 AM by havy1369
3/3 0 Nov 17, 2014 11:37 AM

More options for Neratinib and what we learned from the telecom

Nov 14, 2014 9:57 AM by oliver_67
2/0 1 Nov 14, 2014 4:55 PM by allanacetone

Tivantinib plus Trastuzumab = Cure

Nov 13, 2014 10:03 PM by tivantinib_with_trastuzumab_cure
0/2 4 Nov 18, 2014 3:10 PM by allanacetone

CEO is a manipulator !!!!!!! This will end like IPCT in the next few months !!!!

Nov 14, 2014 10:53 AM by havy1369
1/2 1 Nov 14, 2014 11:43 AM by oliver_67

Losing here with Puma, Check out ACAD...ACAD....ACAD.

Nov 14, 2014 12:46 PM by crecy_war_knight
1/3 1 Nov 22, 2014 12:08 PM by crecy_war_knight

Stick a fork in it.

Nov 14, 2014 8:46 AM by glenn_zax
1/3 3 Nov 14, 2014 12:20 PM by timneff13

This stock had no business at 250 with trials in question

Nov 15, 2014 8:41 PM by bwillis1701
1/4 3 Nov 16, 2014 12:29 PM by bigtime_chutia

Do not short below 200 for now. Stock is an elevator between 200 and 250.

Nov 17, 2014 9:49 AM by mdan599
1/3 3 Nov 17, 2014 10:01 PM by havy1369

I'M OUT.

Nov 14, 2014 9:44 AM by dpalmi1
1/1 1 Nov 14, 2014 11:49 AM by slowboat222

Chatter going on that PBYI is a potential buy-out target by Amgen

Nov 4, 2014 3:46 PM by coria_chick1
1/3 1 Nov 7, 2014 7:47 AM by jeffnrt

GALE receives GRANT FROM THE DEPT, OF DEFENSE in high risk HER3+ patients

Oct 30, 2014 10:46 AM by sayz.simmon
1/1 0 Oct 30, 2014 10:46 AM

don't miss out on over sold GALE shares and 77% effective in phase 2 for HER2. drug i...

Oct 27, 2014 11:09 AM by sayz.simmon
0/1 0 Oct 27, 2014 11:09 AM

gale about to start P. III, D.O.D. suppports Gale phase III, see NYTImes artiicle on Neuva...

Oct 30, 2014 9:38 AM by sayz.simmon
0/1 0 Oct 30, 2014 9:38 AM

MD ANDERSON Cancer Center, Dept of Defense, NYTimes: all say Neuvax breast cancer vaccine ...

Nov 23, 2014 2:45 PM by sayz.simmon
0/1 0 Nov 23, 2014 2:45 PM

PennyStocksWeekly mentions PBYI as a possible double by year end!

Nov 11, 2014 3:04 PM by hesterfralin
0/1 0 Nov 11, 2014 3:04 PM

The subbie right now

Nov 10, 2014 9:21 PM by jackpot77cool
0/1 0 Nov 10, 2014 9:21 PM

Help Us Make it Better!

We are in the process of testing our new message boards.
Please provide your feedback so that we can optimize the user experience.

Go
PBYI
229.18-2.79(-1.20%)Nov 25 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.